Apellis Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APLS Nasdaq 2830 www.apellis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apellis Pharmaceuticals, Inc.

Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst - Mar 5th, 2025 7:04 pm
Apellis Q4 Loss Narrower Than Expected, Syfovre Sales Drive Revenues - Mar 3rd, 2025 3:56 pm
Apellis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations - Mar 1st, 2025 12:48 pm
Apellis Pharmaceuticals Inc (APLS) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and ... - Mar 1st, 2025 7:08 am
Q4 2024 Apellis Pharmaceuticals Inc Earnings Call - Mar 1st, 2025 6:29 am
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q4 Earnings: A Look at Key Metrics - Feb 28th, 2025 2:30 pm
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates - Feb 28th, 2025 1:15 pm
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results - Feb 28th, 2025 12:05 pm
Y-mAbs Therapeutics, Inc. (YMAB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Feb 25th, 2025 3:00 pm
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Feb 24th, 2025 12:00 pm
Why Apellis Pharmaceuticals, Inc. (APLS) is the Most Oversold Pharma Stock to Buy According to Analysts - Feb 23rd, 2025 6:31 pm
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Feb 21st, 2025 3:00 pm
High Growth Tech Stocks In The United States To Watch - Feb 21st, 2025 2:02 pm
Is Apellis Pharmaceuticals (APLS) One of the Most Oversold Healthcare Stocks to Buy Now? - Feb 20th, 2025 5:08 pm
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN - Feb 20th, 2025 7:00 am
Apellis Pharmaceuticals (APLS): Among Top Insider Stock Buys And Sells In January - Feb 18th, 2025 9:12 pm
Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Feb 14th, 2025 12:00 pm
Apellis Pharmaceuticals (NASDAQ:APLS investor one-year losses grow to 58% as the stock sheds US$231m this past week - Feb 13th, 2025 10:32 am
Why Insiders Are Selling Apellis Pharmaceuticals, Inc. (APLS) Recently - Feb 11th, 2025 7:03 pm
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 4th, 2025 9:05 pm